Aristotle University Of Thessaloniki (AUTH)
ΣΥΓΚΡΙΤΙΚΗ ΑΞΙΟΛΟΓΗΣΗ ΝΕΟΤΕΡΩΝ ΠΡΟΣ ΠΑΛΑΙΟΤΕΡΟΥΣ ΔΕΙΚΤΕΣ ΚΑΡΚΙΝΟΥ ΣΤΗ ΔΙΑΓΝΩΣΗ ΤΟΥ ΜΕΤΑΣΤΑΤΙΚΟΥ ΚΑΡΚΙΝΩΜΑΤΟΣ ΤΟΥ ΜΑΣΤΟΥ
Abstract
dc:descriptionTHE LEVELS OF THREE TUMOR MARKERS ALREADY TESTED IN CLINICAL PRACTICE [CEA, TPA, CA IS - 3] AND OF THREE TUMOR MARKERS RECENTLY INTRODUCED IN CLINICAL PRACTICE [TPS, CA 27 - 29, CYFRA 21 - 1] HAVE BEEN MEASURED IN THE SERUM OF 169 PATIENTS WITH BREAST CANCER, 50 PATIENTS WITH BENING BREAST DISEASE AND 90 NORMAL WOMEN. THE SENSITIVITY OF THE TUMOR MARKERS AT EARLY STAGES OF BREAST CANCER WERE: CEA 9%, TPA 9%, CA IS - 3 7%, TPS 19%, CA 27 - 29 31%, CYFRA 21 - 1 0%. THEIR SENSITIVITY AT STAGE III WAS: CEA 27%, TPA 64%, CA IS - 3 50%, TPS 68%, CA 27 - 29 82%, CYFRA 21 - 1 38%. FOR THE METASTATIC PATIENTS OF STAGE IV THEIR SENSITIVITY WAS: CEA 81%, TPA 84%, CA IS - 3 93%, TPS 81% CA 27 - 29 95%, CYFRA 21 - 1 54%. THE MOST SENSITIVE COMBINATIONS, IN PAIRS, OF THE TUMOR MARKERS IN THE SERUM OF STAGE IV PATIENTS WERE FOUND TO BE: CEA AND TPS 98%, CA 27 - 29 AND TPA 97%, CA IS - 3 AND TPS 97%, CA IS - 3 AND TPA 97%. THE SPECIFICITY OF THE TUMOR MARKERS STUDIED IN THIS WORK WAS FOUND TO BE: CEA 91%, TPA 91%, CA IS - 3 89%, TPS 97%, CA 27 - 29 89%, CYFRA 21 - 1 100%.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 1996
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Λιάρος, Γεώργιος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/8774